• Mental Health

The Role of Genetic Testing in Psychiatry

Published: April 23, 2025
Updated: April 23, 2025
4 mins

When it comes to mental health, there’s rarely a cure-all solution. If you’ve ever felt like your treatment plan isn’t quite working – or that it’s been more trial-and-error than science – you’re not alone. But now, thanks to advances in genetic testing and a growing field called pharmacogenomics, we’re able to take a much more personalized approach. 

By looking at your genetic makeup, we can identify whether there might be an underlying genetic syndrome contributing to your symptoms, and just as importantly, how your body is likely to respond to certain medications. It’s a powerful tool that’s helping us move beyond guesswork and into truly customized psychiatric care.

Understanding the Link Between Genetics and Psychiatry

Mental health conditions are complex – and in some cases, the cause may be linked to a person’s genes. The relationship between genetics and psychiatry has become a growing area of interest as we learn more about how specific genetic variations can influence brain development, neurotransmitter function, and ultimately, behavior and mood.

In some individuals, psychiatric symptoms may be a clue to an underlying genetic syndrome. For example, 22q11.2 deletion syndrome (also known as DiGeorge syndrome) is associated not only with physical and developmental challenges but also with an increased risk of schizophrenia, anxiety, and attention-related disorders. Fragile X syndrome, the most common inherited cause of intellectual disability, often presents with features like social anxiety, hyperactivity, and features overlapping with autism. And in Huntington’s disease, psychiatric symptoms such as depression, irritability, and psychosis can appear years before the motor symptoms that typically define the condition.

This is where genetic testing for psychiatry can make a meaningful difference. When a patient presents with complex or treatment-resistant symptoms – especially at an early age or alongside other neurological signs –  genetic testing may help uncover syndromes that would otherwise go unrecognized. 

Identifying a genetic contributor to psychiatric symptoms not only informs diagnosis – it can also shape more targeted care plans, connect families with appropriate support resources, and in some cases, guide decisions about future medical management.

What is Pharmacogenomics?

Pharmacogenomics is the study of how your genes affect the way your body responds to medications. In psychiatry, this information can be especially valuable, since people often respond very differently to the same antidepressant, antipsychotic, or mood stabilizer. What works well for one person might cause side effects – or no effect at all – in someone else.

That’s where pharmacogenomics testing comes in. This type of genetic testing looks at specific gene variations that can influence how your body processes medications. One of the key areas it examines is a group of enzymes known as CYP450 enzymes (short for cytochrome P450). These enzymes play a major role in how drugs are metabolized in the liver. Depending on your genetic makeup, you may metabolize certain medications too quickly, too slowly, or not at all. This makes them less effective or more likely to cause side effects.

SSRIs (selective serotonin reuptake inhibitors) are a common case in which pharmacogenomic testing can be especially helpful. These medications are widely prescribed for depression and anxiety, but people can have very different responses to them. Some people have a variation in the CYP2C19 gene that causes them to break down SSRIs too quickly, meaning the drug doesn’t stay in their system long enough to be effective. Others may metabolize it too slowly, which can lead to higher levels in the blood and a greater risk of side effects like nausea, agitation, or sedation.

By identifying these drug-gene interactions, we can better predict which medications are likely to be a good fit and which ones might not be worth trying. Knowing this ahead of time helps guide more personalized medication decisions – potentially saving weeks or even months of trial and error.

How Pharmacogenomic Testing Improves Treatment Outcomes

One of the biggest challenges in psychiatry is figuring out which medication will work best for a particular patient. It’s not uncommon for someone to try several antidepressants or mood stabilizers before finding one that actually helps – and in the meantime, they may deal with frustrating side effects or feel like they’re not making progress. Pharmacogenomic testing gives us a tool to cut through some of that uncertainty.

By looking at how a person’s genes affect the way they metabolize or respond to medications, we can identify which treatments are more likely to be effective – and which ones might carry a higher risk of side effects. This can be especially helpful when choosing between similar medications, like different SSRIs or antipsychotics. Instead of relying solely on trial and error, we’re using genetic information to guide those decisions from the outset.

In practice, this has already changed treatment plans for many patients. For example, someone with depression who didn’t respond to two different SSRIs might complete pharmacogenomic testing and discover they’re a poor metabolizer of medications that rely on the CYP2D6 enzyme. 

That could explain why the drugs weren’t working as expected. With that information, their provider can switch to an antidepressant that doesn’t rely on that same metabolic pathway – often with better results and fewer side effects.

Ultimately, pharmacogenomic testing supports a more personalized, evidence-based approach to psychiatry. It doesn’t replace clinical judgment, but it adds another layer of insight. This helps healthcare providers tailor treatment in a way that’s more efficient, more targeted, and more aligned with each patient’s unique biology.

When to Consider Genetic Testing in Psychiatry

Genetic testing isn’t necessary for every patient, but there are certain situations where it can provide meaningful insight and guide treatment decisions. Genetic testing may be recommended when someone’s symptoms or response to treatment suggests there could be an underlying genetic factor at play. 

For instance, treatment-resistant depression – where multiple medications haven’t worked or have caused significant side effects – is one of the most common reasons to consider pharmacogenomic testing. It helps healthcare providers and patients alike to understand how the body is processing (or not processing) these medications. 

Testing may also be helpful in cases of early-onset psychiatric illness, especially when symptoms appear in childhood or adolescence and don’t follow a typical course. Similarly, a strong family history of mental illness – especially across multiple generations – can raise questions about inherited genetic factors that may be influencing a person’s condition.

When developmental delays, intellectual disability, or neurological symptoms are also present, genetic testing can help identify syndromes or conditions that may go otherwise undiagnosed. In these cases, uncovering a genetic explanation doesn’t just help shape psychiatric treatment – it can also provide families with a clearer understanding of what’s going on and what to expect over time. 

Limitations and Ethical Considerations

While pharmacogenomics holds promise, it’s important to recognize that it’s not always a perfect science. Genetic testing can offer valuable guidance, but so many other factors influence how someone responds to psychiatric treatment. 

There are also some technical limitations to keep in mind. Not all psychiatric medications have well-established gene-drug interactions, and in some cases, the evidence for changing a treatment based on pharmacogenomic results is still evolving. The results themselves can sometimes be hard to interpret, and different testing companies may provide varying levels of detail and clinical relevance. 

Another practical barrier is insurance coverage. Some plans cover pharmacogenomic testing, especially when it’s deemed medically necessary, but not all do – and out-of-pocket costs can be a hurdle for patients.

Then there are privacy and ethical concerns, especially when dealing with sensitive genetic data in a psychiatric setting. Patients may worry about how their genetic information is stored, who has access to it, or whether it could affect things like life insurance eligibility. That’s why any decision to pursue testing should come with a clear discussion about data protection, consent, and the limits of what the results can tell us.

Despite these challenges, pharmacogenomics remain a useful tool when used thoughtfully and as part of a broader, collaborative care plan.

Where Can I Learn More About Psychiatric Services?

LifeMD makes it easy to access the mental health support you need, with services covered by insurance for around 95% of patients. While LifeMD doesn’t offer genetic testing, LifeMD-affiliated healthcare providers can help you find a treatment plan that works for you and prescribe medications when appropriate. 

Take the first step toward support today.

LifeMD makes it easy to stay on top of your health because talking to a doctor, filling your prescriptions, getting your labs done—and more—are all easy and cost-effective. Come discover a healthcare solution built around you and your life.

Connect with a doctor now!

Join Now